The 12th Beirut Breast Cancer Conference Pharmacy Parallel Session

Navigating Breast Cancer Therapies: Insights, Innovations, and Adherence Challenges

February 17, 2024

11:00am – 1:00pm Beirut Time

In-Person Session

ACC Multipurpose Room #1, AUBMC, Lebanon

Session Planner

Rony Zeenny, Pharm.D., MPH, BCPS, FASHP

Director, Department of Pharmacy

American University of Beirut Medical Center

Beirut, Lebanon

 

Program Overview

Pharmacy session focuses on the essential role of pharmacists in the treatment and care of breast cancer patients. The session aims to educate and update attendees on the latest advancements in medication management, drug interactions, and side-effect mitigation strategies in the context of breast cancer. Participants will have the opportunity to engage with leading experts in the field and gain practical insights into the day-to-day challenges faced by pharmacists working in the oncology setting. Do not miss this essential opportunity to enhance your knowledge and improve patient outcomes.

For the detailed Pharmacy program, please click here.

 

Target Audience

This activity is targeted towards pharmacists, clinical pharmacists, pharmacy technicians, oncologists, and other healthcare professionals who work with breast cancer patients. The session is also relevant for those who are involved in breast cancer research and advocacy, as well as for patients who are interested in learning about the role of pharmacists in their care. This session provides a platform for healthcare professionals to share knowledge, exchange ideas and best practices, and stay up-to-date on the latest developments in the field.

 

Program Objectives

At the end of this session, participants will be able to:

• Distinguish between treatment approaches for HER2-Positive and Triple-Negative Breast Cancer, facilitating informed decision-making in clinical practice.
• Evaluate the impact of clinical pharmacist involvement on oral breast cancer treatment adherence, recognizing challenges and implementing effective strategies for improved medication adherence.
• Implement strategies for managing cardiovascular toxicity in cancer patients, promoting patient safety and optimizing overall healthcare outcomes

 

Register HERE!